CONCEPTT type 1 diabetes pregnancy trial participants get 50/50 chance of free CGM use. Do you qualify?

Type one diabetic? Pregnant? Planning on it?

Qualified trial participants will get a 50 per cent chance of free continuous glucose monitoring (CGM) during pregnancy.

The trial is called CONCEPTT (<–that’s not a typo, there are two T’s).

The goal of this study is to compare the effects of adding CGM to standard therapy versus standard therapy without CGM.

| CONCEPTT trial brochure |

What is the CONCEPTT trial?

  • Study is a randomized, open-label controlled trial funded by JDRF
  • Launched a year ago in Canada, UK, Spain, Italy and the US
  • Qualified participants have a 50/50 chance of receiving a CGM sensor 
  • Those who receive a CGM will use it until 24 weeks after enrollment or if you get pregnant, until completion of your pregnancy
  • You do not have to pay for the sensor & the rest of your care will remain the same
  • You will have the same number of visits to your endocrinologist as usual
  • Blood will be collected and if you are pregnant and deliver, blood from the baby’s umbilical cord will be collected and tested for information about the baby’s insulin levels. This does not hurt the baby.

| CONCEPTT trial brochure |

Participation is 100 per cent voluntary. You may leave at any time without affecting your care.

Do I qualify?

  • Women must either be planning to conceive within six months or be in early pregnancy, up to 13 weeks.
  • They also must be willing to wear the CGM device 24 hours/day. Read more here.

How to find out more

Speak to your own caregiver or contact:

Investigator Dr. Denice Feig at 416-586-8590 or co-ordinator Ms Barbara Cleave at 416-586-8590 ext. 2622

Mount Sinai Hospital

60 Murray St., 5th floor

Toronto, Ontario

Read more:

Optimizing pregnancy outcomes for type 1 diabetes ‘moms-to-be’

I met the co-ordinator of this study, Barbara Cleave at the JDRF Infosium in March. Read my post on the event here Protection Status